Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Moneghetti, Kegan J, Skhiri, Mehdi, Contrepois, Kévin et al. · Scientific reports · 2018 · DOI
Quick Summary
Researchers tested whether measuring immune chemicals (called cytokines) in the blood after exercise could help identify people with ME/CFS. They compared 24 people with ME/CFS to 24 healthy controls and measured 51 different immune markers both before and 18 hours after exercise. They found that the pattern of immune chemicals measured 18 hours after exercise was different enough to reliably distinguish people with ME/CFS from healthy people.
Why It Matters
This research provides objective biological markers that could potentially help diagnose ME/CFS, a disease that currently lacks confirmatory tests and is often diagnosed only after excluding other conditions. Identifying immune abnormalities triggered by exercise may illuminate why patients experience post-exertional malaise and could guide future treatment strategies.
Observed Findings
Cytokine profiles measured 18 hours after exercise achieved reliable discrimination between ME/CFS and control groups (κ = 0.62)
Five cytokines were identified as most discriminatory post-exercise: CD40L, platelet activator inhibitor, IL-1β, IFN-α, and CXCL1
Cardiac structure and exercise capacity did not differ significantly between ME/CFS and control groups
Cardiovascular measurements alone did not reliably differentiate the two groups
Immune marker patterns post-exercise were more informative than baseline measurements
Inferred Conclusions
Post-exercise cytokine profiling may be valuable for objectively identifying ME/CFS patients
The immune dysregulation in ME/CFS may manifest more clearly during post-exercise recovery than at rest
Immune dysfunction rather than primary cardiac dysfunction may be central to ME/CFS pathophysiology
Multiplexed cytokine analysis offers better diagnostic potential than single biomarker approaches
Remaining Questions
Can these cytokine signatures be reproduced in larger, more diverse patient populations and with healthy active controls rather than sedentary controls?
What This Study Does Not Prove
This study does not prove that these cytokine changes cause ME/CFS symptoms or post-exertional malaise—only that they correlate with the condition. The findings were from sedentary controls rather than healthy active individuals, so it remains unclear whether the immune profile distinguishes ME/CFS specifically or simply reflects differences in physical activity level. Results require validation in larger, more diverse populations before clinical implementation.